In a challenging market environment, Immunic, Inc. (NASDAQ:IMUX) stock has recorded a new 52-week low, dipping to $0.92. The biopharmaceutical company, which focuses on developing treatments for ...

Kyverna Therapeutics Inc. (KYTX) stock has reached a new 52-week low, trading at $2.78, down 10.4% in the past week alone, as the biotechnology firm faces a challenging market environment. According ...

Palantir produced $2.8 billion in revenues in 2024, far and above BBAI’s $165 million. While that’s not a dealbreaker, ...

OpenAI o3 has the potential to reqrite the AI playbook, but to achieve this, Nvidia's latest technology and GPUs are the only ...

Inspire Veterinary Partners, Inc. (Nasdaq:IVP) (”Inspire” or the “Company”), an owner and provider of pet health care services throughout the U.S.,today issued a letter to stockholders from Kimball ...

Honasa posted a net profit of Rs 26 crore in Q3 FY25, unchanged from the same period last year, but a sharp recovery from a ...

A growing number of young Americans are drinking their way onto the organ transplant list — particularly women.

We advise caution on Dr. Martens due to risks and challenges. Read here for DOCMF stock's struggles post-IPO and potential ...

Will there be a severe downturn as a result? No one can say for sure, but investing in companies that can handle market ...

The surgeon added that younger patients have been inquiring about facelifts more often, and more patients are looking for ...

Save up to 70% off on baby gear! From baby monitors to a breast pump starter set, you won't want to miss these deals.